Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives

F Husain‐Syed, HJ Gröne, B Assmus, P Bauer… - ESC heart …, 2021 - Wiley Online Library
Venous congestion has emerged as an important cause of renal dysfunction in patients with
cardiorenal syndrome. However, only limited progress has been made in differentiating this …

Lung-kidney interactions and their role in chronic kidney disease-associated pulmonary diseases

S Bollenbecker, B Czaya… - American Journal of …, 2022 - journals.physiology.org
Chronic illnesses rarely present in a vacuum, devoid of other complications, and chronic
kidney disease is hardly an exception. Comorbidities associated with chronic kidney …

ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery

DP McGlothlin, J Granton, W Klepetko… - The Journal of Heart and …, 2022 - Elsevier
Pulmonary hypertension (PH) is a risk factor for morbidity and mortality in patients
undergoing surgery and anesthesia. This document represents the first international …

Pulmonary hypertension subtypes and mortality in CKD

DL Edmonston, KS Parikh, S Rajagopal… - American Journal of …, 2020 - Elsevier
Rationale & Objective Pulmonary hypertension (PH) contributes to cardiovascular disease
and mortality in patients with chronic kidney disease (CKD), but the pathophysiology is …

Diagnosis and management of pulmonary hypertension in patients with CKD

CP Walther, V Nambi, NA Hanania… - American Journal of …, 2020 - Elsevier
Pulmonary hypertension (PH) is a highly prevalent and important condition in adults with
chronic kidney disease (CKD). In this review, we summarize the definition of PH, discuss its …

Prevalence and mortality of pulmonary hypertension in ESRD: a systematic review and meta-analysis

NC Schoenberg, RG Argula, ES Klings, KC Wilson… - Lung, 2020 - Springer
Introduction Pulmonary hypertension (PH) in the setting of end-stage renal disease (ESRD)
has important prognostic and therapeutic consequences. We estimated the prevalence of …

Epidemiology, pathogenesis, and clinical approach in group 5 pulmonary hypertension

M Al-Qadi, B LeVarge, HJ Ford - Frontiers in Medicine, 2021 - frontiersin.org
Pulmonary hypertension (PH) is recognized to be associated with a number of comorbid
conditions. Based on these associations, PH is classified into 5 groups, considering …

Emerging therapies: The potential roles SGLT2 inhibitors, GLP1 agonists, and ARNI therapy for ARNI pulmonary hypertension

NE King, E Brittain - Pulmonary Circulation, 2022 - Wiley Online Library
Pulmonary hypertension (PH) is a highly morbid condition. PH due to left heart disease (PH‐
LHD) has no specific therapies and pulmonary arterial hypertension (PAH) has substantial …

The prevalence of pulmonary hypertension among maintenance dialysis patients with ESRD and its associated factors: a retrospective study

Y Zhang, XH Ding, R Rao, Y Wang, F Pang… - Frontiers in …, 2020 - frontiersin.org
Aim: To determine the prevalence of pulmonary hypertension (PH) and its associated factors
among end-stage renal disease (ESRD) patients who underwent maintenance dialysis …

Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes

K Zeder, ED Siew, G Kovacs, EL Brittain… - Nature Reviews …, 2024 - nature.com
Pulmonary hypertension (PH) is common in patients with chronic kidney disease (CKD) or
kidney failure, with an estimated prevalence of up to 78% in those referred for right-heart …